Lakefront Receives Transparency Notification from Madison Avenue Partners
Madison Avenue Partners disclosed that it has crossed the 5% ownership threshold in Lakefront Biotherapeutics, holding a 5.31% stake. The group, including affiliates, owns 3,498,892 voting rights out of 65,897,071 total outstanding shares following acquisitions on June 15.
Key figures
- Threshold crossed
- 5%
- Shares outstanding
- 65897071
- Voting rights held
- 3498892
- Ownership percentage
- 5.31%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.